← stocks-llm New chat

Doximity (DOCS) — insider trading

Health Care

Doximity (DOCS) has 31 reported SEC Form 4 insider transactions in our data, including 5 open-market sales among the most recent 31 (latest 2026-07-13).

Recent Form 4 transactions

DateInsiderRoleTypeSharesPriceValueFiling
2026-07-13 Benjamin Regina M. Director Grant / award / vesting 21,314 $0.00 $0 Form 4
2026-06-08 Sitaram Siddharth Officer (Interim PAO) Conversion of derivative (derivative) 5,000 $0.00 $0 Form 4
2026-06-08 Sitaram Siddharth Officer (Interim PAO) Option exercise / conversion (derivative) 5,000 $0.00 $0 Form 4
2026-06-08 Sitaram Siddharth Officer (Interim PAO) Option exercise / conversion (derivative) 5,000 $0.00 $0 Form 4
2026-06-08 Sitaram Siddharth Officer (Interim PAO) Open-market sale 2,444 $20.41 $49.9K Form 4
2026-06-08 Sitaram Siddharth Officer (Interim PAO) Conversion of derivative 5,000 Form 4
2026-05-15 ZATZ STEVEN L Officer (President) Grant / award / vesting 55,524 $0.00 $0 Form 4
2026-05-15 Tangney Jeffrey Director, Officer (Chief Executive Officer), 10% owner Shares withheld for taxes / exercise cost 14,964 $18.01 $269.5K Form 4
2026-05-15 Tangney Jeffrey Director, Officer (Chief Executive Officer), 10% owner Grant / award / vesting 322,614 $0.00 $0 Form 4
2026-05-15 Sitaram Siddharth Officer (Interim PFO and PAO) Shares withheld for taxes / exercise cost 1,246 $18.01 $22.4K Form 4
2026-05-11 Sitaram Siddharth Officer (Interim PFO and PAO) Conversion of derivative (derivative) 5,000 $0.00 $0 Form 4
2026-05-11 Sitaram Siddharth Officer (Interim PFO and PAO) Option exercise / conversion (derivative) 5,000 $0.00 $0 Form 4
2026-05-11 Sitaram Siddharth Officer (Interim PFO and PAO) Option exercise / conversion (derivative) 5,000 $0.00 $0 Form 4
2026-05-11 Sitaram Siddharth Officer (Interim PFO and PAO) Open-market sale 2,309 $25.77 $59.5K Form 4
2026-05-11 Sitaram Siddharth Officer (Interim PFO and PAO) Conversion of derivative 5,000 Form 4
2026-05-07 Wampler Kira Scherer Director Conversion of derivative (derivative) 9,000 $0.00 $0 Form 4
2026-05-07 Wampler Kira Scherer Director Option exercise / conversion (derivative) 9,000 $0.00 $0 Form 4
2026-05-07 Wampler Kira Scherer Director Option exercise / conversion (derivative) 9,000 $0.00 $0 Form 4
2026-05-07 Wampler Kira Scherer Director Open-market sale 9,000 $26.06 $234.5K Form 4
2026-05-07 Wampler Kira Scherer Director Conversion of derivative 9,000 Form 4
2026-04-10 Sitaram Siddharth Officer (Interim PFO and PAO) Conversion of derivative (derivative) 5,000 $0.00 $0 Form 4
2026-04-10 Sitaram Siddharth Officer (Interim PFO and PAO) Option exercise / conversion (derivative) 5,000 $0.00 $0 Form 4
2026-04-10 Sitaram Siddharth Officer (Interim PFO and PAO) Option exercise / conversion (derivative) 5,000 $0.00 $0 Form 4
2026-04-10 Sitaram Siddharth Officer (Interim PFO and PAO) Open-market sale 2,427 $21.09 $51.2K Form 4
2026-04-10 Sitaram Siddharth Officer (Interim PFO and PAO) Conversion of derivative 5,000 Form 4
2026-03-10 Sitaram Siddharth Officer (Interim PFO and PAO) Conversion of derivative (derivative) 5,000 $0.00 $0 Form 4
2026-03-10 Sitaram Siddharth Officer (Interim PFO and PAO) Option exercise / conversion (derivative) 5,000 $0.00 $0 Form 4
2026-03-10 Sitaram Siddharth Officer (Interim PFO and PAO) Option exercise / conversion (derivative) 5,000 $0.00 $0 Form 4
2026-03-10 Sitaram Siddharth Officer (Interim PFO and PAO) Open-market sale 2,319 $25.37 $58.8K Form 4
2026-03-10 Sitaram Siddharth Officer (Interim PFO and PAO) Conversion of derivative 5,000 Form 4
2025-11-15 Benjamin Regina M. Director Grant / award / vesting 9,750 $0.00 $0 Form 4/A

Ask the chat about DOCS's insider activity →

Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.

Source: SEC EDGAR Form 3/4/5. See the full company profile: Doximity (DOCS).

Last updated 2026-07-13 (most recent filing date).

Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.